| 1 | High-Dose Dexamethasone Combined with Orelabrutinib (D12160) | [2] Dexamethasone Dexamethasone, Orelabrutinib | [4] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Orelabrutinib
(D12160) 💬
| [2] BTK BTK, NR3C1 💬
| [8] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 2 | Orelabrutinib (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [5] 13 13, 49, 53, 61, 63 💬
|
| 3 | Orelabrutinib (High Dose) (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 49 49 💬
|
| 4 | Orelabrutinib (Low Dose) (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 49 49 💬
|
| 5 | Orelabrutinib( higher dose) (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 6 | Orelabrutinib( lower dose) (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 63 63 💬
|
| 7 | Orelabrutinib-100 (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 8 | Orelabrutinib-150 (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|
| 9 | Orelabrutinib-50 (D12160) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
(D12160) 💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 61 61 💬
|